A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Cue Biopharma
Cue Biopharma
National Cancer Institute (NCI)
Sumitomo Pharma America, Inc.
Masonic Cancer Center, University of Minnesota
University of Louisville
City of Hope Medical Center
National Cancer Institute (NCI)
Indiana University
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)